Raborn et al 1990 J Canad.Dent. Asoc 56 (8) 779-781, Aug. 1, 1990. |
Larson, M.J. et al., “Efficacy of a Fibrin Hemostatic Bandage in Controlling Hemorrhage From Experimental Arterial Injuries,” Arch. Surg. 130:420-422 (1995). |
Lasa, C.I. et al., “Effect of Fibrin Glue and Opsite on Open Wounds in DB/DB Mice,” J. Surg. Res. 54:202-206 (1993). |
MacPhee, M., “Fibrin Sealant Based Bandages and Foam: Hemostatic Devices for Treatment of Combat Casualties on the Battlefield,” Presented at the Advanced Technology Applications to Combat Casualty Care (ATACCC) conference (May 1995). |
MacPhee, M., “Field-Ready Fibrin Sealant Based Hemostatic Devices,” Presented at the 29th Penner Blood Conference (May 1995). |
Stemberger, A. and Blümel, G., “Fibrinogen-Fibrin Conversion and Inhibition of Fibrinolysis,” Thorac. Cardiovasc. Surgeon 30:209-214 (1982). |
Epstein, G.H. et al., “A New Autologous Fibrinogen-Based Adhesive For Otologic Surgery,” Ann. Otol. Rhinol. Laryngol. 95:40-45 (1986). |
Gersdorff, M.C.H. et al., “A New Procedure For Bone Reconstruction In Oto-Microsurgery: A Mixture Of Bone Dust And Fibrinogen Adhesive,” Laryngosc. 95:1278-1280 (1985). |
Härting, F. et al., “Glued Fixation of Split-Skin Graft to the Bony Orbit Following Exenteration,” Plas. Reconstruc. Surg. 76(4):633-635 (1985). |
Ikossi-O'Connor, M.G. et al., “The Role of Fibrin Adhesive in Vascular Surgery,” J. Surg. Oncol. 23:151-152 (1983). |
Petrelli, N.J. et al., “The Application of Tissue Adhesives in Small Bowel Anastomoses,” J. Surg. Oncol. 19:59-61 (1982). |
Thompson, D.F. et al., “Fibrin Glue: A Review Of Its Preparation, Efficacy, And Adverse Effects As A Topical Hemostat,” Dr. Intell. Clin. Pharm. 22:946-952 (1988). |
Thorson, G.K. et al., “The Role of the Tissue Adhesive Fibrin Seal (FS) in Esophageal Anastomoses,” J. Surg. Oncol. 24:221-223 (1983). |
Adelmann-Grill et al., “Chemotactic Migration of Normal Dermal Fibroblasts Towards Epidermal Growth Factor and Its Modulation by Platelet-Derived Growth Factor and Transforming Growth Factor-Beta,” European J. Cell. Biol. 51:322-326 (Apr., 1990). |
Akrami et al., “Replacement of the Thoracic Aorta by Sealed Dacron Prostheses,” Thoraxchirurgie 26:144-147 (1978). |
Albrektsson et al., “Fibrin Adhesive System (FAS) Influence on Bone Healing Rate,” Acta Orthop. Scand. 53:757-763 (1982). |
Allen et al., “Influence of Endothelial Cell Seeding on Platelet Deposition and Patency in Small-Diameter Dacron Arterial Grafts,” J. Vasc. Surg. 1:224-233 (1984). |
Arbes et al., “First Clinical Experience with Heterologous Cancellous Bone Grafting Combined with the Fibrin Adhesive System (F.A.S.),” Arch. Orthop. Traumat. Surg. 98:183-188 (1981). |
Baird et al., “Fibroblast Growth Factors,” British Medical Bulletin 45(2):438-452 (1989). |
Berger et al., “Healing of Arterial Prostheses in Man: Its Incompleteness,” Ann. Surg. 175(1):118-127 (1972). |
Borst et al., “Fibrin Adhesive: An Important Hemostatic Adjunct in Cardiovascular Operations,” J. Thorac. Cardiovasc. Surg. 84:548-553 (1982). |
Bösch, V.P., “Autologous Cancellous Bone Grafting in Rabbits Using a Fibrinogen Adhesive System,” Wiener klinische Wochenschrift 91(18):628-633 (1979). |
Bösch, V.P., “Bone Grafting with Fibrin Glue,” Wein Klin. Wochenschr. 93(Suppl. 124):3-26 (1981). |
Bösch, V.P., “Experimental Investigations of the Effect of the Fibrin Adhesive on the Kiel Heterologous Bone Graft,” Arch. Orthop. Traumat. Surg. 96:177-185 (1980). |
Bösch et al., “The Technic of Fibrin Glue in Cancellous Bone Transplants,” Arch. Orthop. Unfall-Chir. 90:63-75 (1977). |
Burgess et al., “The Heparin-Binding (Fibroblast) Growth Factor Family of Proteins,” Annual Rev. Biochem. 58:575-606 (1989). |
Byrne et al., “Effect of Fibrin Glues on the Mechanical Properties of Healing Wounds,” Br. J. Surg. 78:841-843 (Jul., 1991). |
Carter et al., “Clinical Experience with Crude Preparations of Growth Factors in Healing of Chronic Wounds in Human Subjects,” in: Growth Factors and Other Aspects of Wound Healing: Biological and Clinical Implications, pp. 303-317 (1988). |
Clowes et al., “Graft Endothelialization: The Role of Angiogenic Mechanisms,” J. Vascular Surgery 13(5):734-736 (May, 1991). |
Clowes et al., “Mechanisms of Arterial Graft Healing,” Am. J. Pathol. 123(2):220-230 (1986). |
Conant et al., “Treatment of Condylomata Acuminata with Itralesional 5-Fluorouracil Therapeutic Implant (MPI 5003),” Clinical Res. 39(4):818A (Dec., 1991). |
Cziperle et al., “Enhanced Endothelialization of Expanded Polytetrafluoroethylene Grafts by Heparin Binding Growth Factor-Type I (HBGF-1) Pretreatment,” Presented at the Society of University Surgeons (Feb., 1992). |
Davidson et al., “Mechanisms of Accelerated Wound Repair Using Epidermal Growth Factor and Basic Fibroblast Growth Factor,” in: Growth Factors and Other Aspects of Wound Healing: Biological and Clinical Implications, Alan R. Liss, Inc., pp. 63-75 (1988). |
Deyerling et al., “A Suspension of Fibrin Glue and Antibiotic for Local Treatment of Myocotic Aneurysms in Endocarditis—An Experimental Study,” Thorac. Cardiovasc. Surgeon 32:369-372 (1984). |
Dresdale et al. “Hemostatic Effectiveness of Fibrin Glue Derived from Single-Donor Fresh Frozen Plasma,” Annals of Thoracic Surgery 40(4):385-387 (1985). |
Dresdale et al., “Preparation of Fibrin Glue from Single-Donor Fresh-Frozen Plasma,” Surgery 97(6):750-755 (1985). |
Durham et al., “A Method for Preparation of Fibrin Glue,” J. Laryngology and Otology 101:1182-1186 (1987). |
Dvorak et al., “Fibrin Containing Gels Induce Angiogenesis,” Lab. Invest. 57(6):673-686 (1987). |
Foxall et al., “Adult Human Endothelial Cell Coverage of Small-Caliber Dacron and Polytetrafluoroethylene Vascular Prostheses in Vitro,” J. Surg. Res. 41:158-172 (1986). |
Froesch et al., “Actions of Insulin-Like Growth Factors,” Ann. Rev. Physiol. 47:443-467 (1985). |
Gibble et al., “Fibrin Glue: The Perfect Operative Sealant,” Transfusion 30(8):741-747 (Aug., 1990). |
Gospodarowicz et al., “Structural Characterization and Biological Functions of Fibroblast Growth Factor,” Endocrine Reviews 8(2):95-114 (1987). |
Goudarzi, Y.M. “Clinical Experiences with a Fibrin-Nebacetin Bone Marrow Combination in the Treatment of Chronic Bone Infections and as Local Infection Prophylaxis in Non-Infected Bone Diseases,” Akt. Traumatol. 13:205-209 (1983). |
Graham et al., “Expanded Polytetrafluoroethylene Vascular Prostheses Seeded with Enzymatically Derived and Cultured Canine Endothelial Cells,” Surgery 91(5):550-559 (1982). |
Greco et al., “Fibrin-Antibiotic Mixtures: An in Vitro Study Assessing the Possibility of Using a Biologic Carrier for Local Drug Delivery,” J. Biomedical Materials Res. 25:39-51 (Jan., 1991). |
Greenhalgh et al., “PDGF and FGF Stimulate Wound Healing in the Genetically Diabetic Mouse,” Am. J. Path. 136(6):1235-1246 (Jun., 1990). |
Greisler et al., “Biomaterial Pretreatment with ECGF to Augment Endothelial Cell Proliferation,” J. Vasc. Surg. 5(2):393-399 and 402 (1987). |
Greisler et al., “Endothelial Cell Growth Factor Attachment to Biomaterials,” Trans. Am. Soc. Artif. Intern. Organs. XXXII:346-349 (1986). |
Greisler et al., “Enhanced Endothelialization of Expanded Polytetrafluoroethylene Grafts by Fibroblast Growth Factor Type 1 Pretreatment,” Surgery 112(2):244-255 (Aug., 1992). |
Greisler et al., “Enhancement of Polytetrafluoroethylene Endothelialization by Pretreatment with Fibrin Glue Containing Heparin Binding Growth Factor-Type I (HBGF-1),” Proc. Cardiovascular Science and Technology Conf., p. 50 (Dec. 2-4, 1991). |
Gundry et al., “A Quantitative and Qualitative Comparison of Fibrin Glue, Albumin, and Blood as Agents to Pretreat Porous Vascular Grafts,” J. of Surgical Res. 43:75-77 (1987). |
Harker et al., “Platelet Consumption by Arterial Prostheses: The Effects of Endothelialization and Pharmacologic Inhibition of Platelet Function,” Ann. Surg. 186(5):594-601 (1977). |
Harrison et al., “Osteogenin Promotes Reexpression of Cartilage Phenotype by Dedifferentiated Articular Chondrocytes in Serum-Free Medium,” Exp. Cell Res. 192:340-345 (Fall, 1991). |
Hattori, T., “Experimental Investigations of Osteogenesis and Chondrogenesis by Implant of BMP-Fibrin Glue Mixture,” J. Jpn. Orthop. Assoc. 64:824-834 (after Jun., 1990). |
Haverich et al., “Histopathological Evaluation of Woven and Knitted Dacron Grafts for Right Ventricular Conduits: A Comparative Experimental Study,” Annals of Thoracic Surgery 37(5):404-411 (1984). |
Haverich et al., “Pericardial Flap-Plasty for Protection of the Tracheal Anastomosis in Heart-Lung Transplantation,” J. Cardiac Surgery 4(2):136-139 (1989). |
Haverich et al., “Prevention of Graft Infection by Bonding of Gentamycin to Dacron Prostheses,” J. Vasc. Surg. 15(1):187-193 (Jan., 1992). |
Haverich et al., “The Use of Fibrin Glue for Sealing Vascular Prostheses of High Porosity,” Thorac. Cardiovasc. Surgeon 29:252-254 (1981). |
Hayek et al., “An in Vivo Model for Study of the Angiogenic Effects of Basic Fibroblast Growth Factor,” Biochem. Biophys. Res. Commun. 147(2):876-880 (1987). |
Herring et al., “Endothelial Seeding of Polytetrafluoroethylene Popliteal Bypasses,” J. Vasc. Surg. 6:114-118 (1987). |
Jarrell et al., “Human Adult Endothelial Cell Growth in Culture,” J. Vasc. Surg. 1:757-764 (1984). |
Jonas et al., “Biological Sealants and Knitted Dacron Conduits: Comparison of Collagen and Fibrin Glue Pretreatments in Circulatory Models,” Annals of Thoracic Surgery 44:283-290 (1987). |
Jonas et al., “Biological Sealants and Knitted Dacron: Porosity and Histological Comparisons of Vascular Graft Materials With and Without Collagen and Fibrin Glue Pretreatments,” Annals of Thoracic Surgery 41:657-663 (1986). |
Karck et al., “Pretreatment of Prosthetic Valve Sewing-Ring with the Antibiotic/Fibrin Sealant Compound as a Prophylactic Tool Against Prosthetic Valve Endocarditis,” Eur. J. Cardio-Thorac. Surg. 4:142-146 (Mar., 1990). |
Kawamura et al., “Human Fibrin is a Physiologic Delivery System for Bone Morphogenetic Protein,” Clinical Orthopaedics and Related Res. 235:302-310 (1988). |
Kempczinski et al., “Endothelial Cell Seeding of a New PTFE Vascular Prosthesis,” J. Vasc. Surg. 2:424-429 (1985). |
Kesler et al., “Enhanced Strength of Endothelial Attachment on Polyester Elastomer and Polytetrafluoroethylene Graft Surfaces with Fibronectin Substrate,” J. Vasc. Surg. 3:58-64 (1986). |
Knighton et al., “Classification and Treatment of Chronic Nonhealing Wounds,” Ann. Surg. 204(3):322-330 (1986). |
Knighton et al., “Regulation of Cutaneous Wound Healing by Growth Factors,” Clinical Materials 8:229-242 (1991—received in the National Library of Medicine in Feb., 1992). |
Knighton et al., “The Use of Platelet Derived Wound Healing Formula in Human Clinical Trials,” in: Growth Factors and Other Aspects of Wound Healing: Biological and Clinical Implications, pp. 319-329 (1988). |
Kovács et al., “Biolplast® Fibrin Coagulum in Large Cystic Defects of the Jaw,” Intl. J. Oral Surg. 5:111-116 (1976). |
Köveker, G., “Clinical Application of Fibrin Glue in Cardiovascular Surgery,” Thorac. Cardiovasc. Surgeon 30:228-229 (1982). |
Köveker et al., “Clinical Experience with Fibrin Glue in Cardiac Surgery,” Thorac. Cardiovasc. Surgeon 29:287-289 (1981). |
Köveker et al., “Reduction of Thrombogenicity in Small-Diameter Vascular Prostheses Seeded with Autologous Endothelial Cells,” Thorac. Cardiovasc. Surgeon 34:49-51 (1986). |
Kram et al., “Antibacterial Effects of Fibrin Glue-Antibiotic Mixtures,” J. Surgical Res. 50:175-178 (1991—presented Apr. 28-May 2, 1989). |
Kram et al., “Fibrin Glue Sealing of Polytetrafluoroethylene Vascular Graft Anastomoses: Comparison with Oxidized Cellulose,” J. Vasc. Surg. 8(5):563-568 (1988). |
Kratzat et al., “Clinical Experiences with the Fibrin-Antibiotic Combination in Infections of the Bones and Soft Parts,” Akt. Chir. 17:58-62 (1982). |
Kratzat et al., “Erste Klinische Enfahrungen mit dem Fibrin-Antibiotikum-Verbund beider osteomyelitis,” Orthop. Praxis 17:852-855 (1981). |
Kratzat et al., “Klinische Erfahrungen mit dem Fibrin-Antibiotikum-Verbund bei Knochen-und Weichteilinfektionen,” in: Fibrinkleber in Orthopadie und Traumatologie, Cotta et al., eds., Thieme Verlag, Stuttgart, pp. 200-204 (1982). |
Kreider et al., “Concordance of Condylomata Acuminata Responses to Treatment with Intralesional MPI 5003 and Papiloma Responses in the Shope Rabbit Papilloma Model System,” Skin Pharmacol. 5(4):201-202 (Oct., 1992). |
Ksander et al., “The Effect of Platelet Releasate on Wound Healing in Animal Models,” J. Am. Acad. Dermatol. 22(No. 5, Part I):781-791 (May, 1990). |
Lasa et al., “Osteoregeneration Using a Fibrin Sealant Delivery Vehicle for Demineralized Bone Matrix,” J. Cell. Biochem. Suppl. 0(17 Part E):162 Abstract No. RZ 217 (Mar. 29-Apr. 25, 1993). |
Lerner et al., “Current Status of Surgical Adhesives,” J. Surg. Res. 48:165-181 (Feb., 1990). |
Lindner et al., “Basic Fibroblast Growth Factor Stimulates Endothelial Regrowth and Proliferation in Denuded Arteries,” J. Clin. Invest. 85:2004-2008 (Jun., 1990). |
Lobb, R.R., “Clinical Applications of Heparin-Binding Growth Factors,” Eur. J. Clin. Invest. 18:321-336 (1988). |
Lucht et al., “Fibrin Sealant in Bone Transplantation,” Acta. Orthop. Scand. 57:19-24 (1986). |
Luyten et al., “Purification and Partial Amino Acid Sequence of Osteogenin, a Protein Initiating Bone Differentiation,” J. Biol. Chem. 264(23):13377-13380 (1989). |
Lynch et al., “Growth Factors in Wound Healing,” J. Clin. Invest. 84:640-646 (1989). |
Mark et al., “Repair of Calvarial Nonunions by Osteogenin, A Bone-Inductive Protein,” Plastic and Reconstructive Surgery 86(4):623-630 (Oct., 1990). |
Massagué, J., “The TGF-β Family of Growth and Differentiation Factors,” Cell 49:437-438 (1987). |
Matras, H., “Fibrin Seal: The State of the Art,” J. Oral Maxillofac. Surg. 43:605-611 (1985). |
McGee et al., “Recombinant Basic Fibroblast Growth Factor Accelerates Wound Healing,” J. Surg. Res. 45:145-153 (1988). |
Miller et al., “Basal Cell Carcinomas Histologically Resolved After Treatment with Intralesional 5-Fluorouracil Therapeutic Implant,” Proc. of the Amer. Assoc. for Cancer Res. 32:420 Abstract No. 2496 (Mar., 1991). |
Montesano et al., “Basic Fibroblast Growth Factor Induces Angiogenesis In Vitro,” PNAS USA 83:7297-7301 (1986). |
Moore et al., “Development of an Infection-Resistant Vascular Prosthesis,” Arch. Surg. 116:1403-1407 (1981). |
Mustoe et al., “Accelerated Healing of Incisional Wounds in Rats Induced by Transforming Growth Factor-β,” Science 237:1333-1336 (1987). |
Orenberg et al., “The Effect of Intralesional 5-Fluorouracil Therapeutic Implant (MPI 5003) for Treatment of Basal Cell Carcinoma,” J. Am. Acad. Dermatol. 27:723-728 (Nov., 1992). |
Yu and Palecek et al., “Pharmacokinetics and Clinical Application of the Intralesional Methotrexate Therapeutic Implant,” Proc. Annu. Meet. Am. Soc. Clin. Oncol. 11:100 Abstract No. 222 (Mar., 1992). |
Pierce et al., “In Vivo Incisional Wound Healing Augmented by Platelet-Derived Growth Factor and Recombinant c-sis Gene Homodimeric Proteins,” J. Exp. Med. 167:974-987 (1988). |
Pop et al., “Experimental Covering of the Dental Pulp in the Dog with Biological Substances,” Chemical Abstracts 72:209 Abstract No. 119944n (1970). |
Presta et al., “Basic Fibroblast Growth Factor Requires a Long-Lasting Activation of Protein Kinase C to Induce Cell Proliferation in Transformed Fetal Bovine Aortic Endothelial Cells,” Cell Regulation 2:719-726 (Sep., 1991). |
Puumala et al., “Intraventricular Infusion of HBGF-2 Promotes Cerebral Angiogenesis in Wistar Rat,” Brain Res. 534:283-286 (Nov., 1990). |
Radomski et al., “Initial Adherence of Human Capillary Endothelial Cells to Dacron,” J. Surgical Res. 42:133-140 (1987). |
Ramalanjaona et al., “The Effect of Fibronectin Coating on Endothelial Cell Kinetics in Polytetrafluoroethylene Grafts,” J. Vasc. Surg. 3:264-272 (1986). |
Redl et al., “Fibrinkleber-Antibiotika-Gemische—Festigkeit und Elutionsverhalten,” in: Fibrinkleber in Orthopadie und Traumatologie, Cotta et al., eds., Thieme Verlag, Stuttgart, pp. 178-181 (1982). |
Redl et al., “In Vitro Properties of Mixtures of Fibrin Seal and Antibiotics,” Biomaterials 4:29-32 (1983). |
Roberts et al., “Transforming Growth Factor β,” Advances in Cancer Res. 51:107-141 (1988). |
Rothe et al., “Growth Factors: Their Biology and Promise in Dermatologic Diseases and Tissue Repair,” Arch. Dermatol. 125:1390-1398 (1989). |
Rovee, D.T., “Evolution of Wound Dressings and Their Effects on the Healing Process,” in: Clinical Materials, Elsevier Science Publishers Ltd., England, pp. 183-188 (1991). |
Sakurai et al., “Controlled Release of Sisomicin from Fibrin Glue,” J. Controlled Release 18:39-44 (Jan., 1992). |
Sauvage et al., “Interspecies Healing of Porous Arterial Prostheses,” Arch. Surg. 109:698-705 (1974). |
Schlag et al., “Fibrin Sealant in Orthopedic Surgery,” Clinical Orthopaedics and Related Res. 227:269-285 (1988). |
Schrenk et al., “Fibrin Glue Coating of e-PTFE Prostheses Enhances Seeding of Human Endothelial Cells,” Thorac. Cardiovasc. Surgeon 35:6-10 (1987). |
Schultz et al., “Epithelial Wound Healing Enhanced by Transforming Growth Factor-α and Vaccinia Growth Factor,” Science 235:350-352 (1987). |
Schwarz et al., “The Influence of Fibrin Sealant on Demineralized Bone Matrix-Dependent Osteoinduction,” Clinical Orthopaedics and Related Res. 238:282-287 (1989). |
Shindo et al., “Improved Patency of Collagen-Impregnated Grafts After In Vitro Autogenous Endothelial Cell Seeding,” J. Vasc. Surg. 6:325-332 (1987). |
Shoemaker et al., “Effects of Fibrin Sealant on Incorporation of Autograft and Xenograft Tendons Within Bone Tunnels,” Am. J. Sports Med. 17(3):318-324 (1989). |
Silbermann, M., “In Vitro Systems for Inducers of Cartilage and Bone Development,” Biomaterials 11:47-49 (Jul., 1990). |
Stark et al., “Experience with Fibrin Seal (Tisseel) in Operations for Congenital Heart Defects,” Annals of Thoracic Surgery 38(4):411-413 (1984). |
Sugie et al., “The Chemical Modification of Fibrin Film as Artificial Skin,” Chemical Abstracts 85:318 Abstract No.182381k (1976). |
Thompson et al., “Heparin-Binding Growth Factor 1 Induces the Formation of Organoid Neovascular Structures In Vivo,” PNAS USA 86:7928-7932 (1989). |
Silberstein et al., “An Autologous Fibrinogen-Based Adhesive for Use in Otologic Surgery,” Transfusion 28(4):319-321 (1988). |
Spotnitz et al.. “Fibrin Glue from Stored Human Plasma,” The American Surgeon 53(8):460-462 (1987). |
Sprugel et al., “The Effects of Different Growth Factors in Subcutaneous Wound Chambers,” in: Growth Factors and Other Aspects of Wound Healing: Biological and Clinical Implications, pp. 77-91 (1988). |
Thompson et al., “Site-Directed Neovessel Formation In Vivo,” Science 241:1349-1352 (1988). |
Tsuboi et al., “Recombinant Basic Fibroblast Growth Factor Stimulates Wound Healing in Healing-Impaired db/db Mice,” J. Exp. Med. 172:245-251 (Jul., 1990). |
Ulatowski et al., “A Biological Adhesive System and Antibiotics for the Enhancement of Wound Healing,” Fortschr. Med. 99:864-868 (1981). |
Ulatowski et al., “Neue Aspekte der Anwendung eines erweiterten Fibrinklebesystems (FKS),” Orthop. Praxis 15:795-799 (1979). |
Ulatowski et al., “Pharmakokinetik eines Fibrinantibiotikumverbundes,” in: Fibrinkleber in Orthopadie und Traumatologie, Cotta et al., eds., Thieme Verlag, Stuttgart, pp. 196-199 (1982). |
Urist et al., “Bone Formation in Implants of Partially and Wholly Demineralized Bone Matrix,” Clinical Orthopaedics and Related Res. 71:271-278 (1970). |
Urist et al., “Bone Morphogenesis in Implants of Insoluble Bone Gelatin,” PNAS USA 70(12 Part I):3511-3515 (1973). |
Walterbusch et al., “Clinical Experience with Fibrin Glue for Local Bleeding Control and Sealing of Vascular Prostheses,” Thorac. Cardiovasc. Surgeon 30:234-235 (1982). |
Wang et al., “Bone Morphogenetic Proteins and Bone Repair,” J. Cell Biochem. Suppl. 0(15 Part F):161 (Jan., 1991). |
Watkins et al., “Adult Human Saphenous Vein Endothelial Cells: Assessment of Their Reproductive Capacity for Use in Endothelial Seeding of Vascular Prostheses,” J. Surg. Res. 36:588-596 (1984). |
Weisman et al., “Biochemical Characterization of Autologous Fibrinogen Adhesive,” Laryngoscope 97:1186-1190 (1987). |
Williams et al., “Adult Human Endothelial Cell Compatibility with Prosthetic Graft Material,” J. Surgical Res. 38:618-629 (1985). |
World Patents Index English translation of title and abstract of German patent application DE 3,037,270 (AP1). |
World Patents Index English translation of title and abstract of Japanese patent application JP 60-204725 (AP2). |
Yu et al., “Comparison of Antitumor Effects of Treatment Sequence of Fluorouracil (FU) and Cisplatin (Pt) Therapeutic Implants in a Mouse Tumor Model,” Proc. Annu. Meet. Am. Soc. Clin. Oncol. 11:100 Abstract No. 223 (Mar., 1992). |
Zilch et al., “Diffusionsverhalten von Cefotaxim aus der Fibrin-Antibiotika-Plombe im Tierversuch,” in: Fibrinkleber in Orthopadie und Traumatologie, Cotta et al., eds., Thieme Verlag, Stuttgart, pp. 191-195 (1982). |
Zilch et al., “The Sustained Release of Cefotaxim from a Fibrin-Cefotaxim Compound in Treatment of Osteitis,” Arch. Orthop. Trauma Surg. 106:36-41 (1986). |
Zilla et al., “Use of Fibrin Glue as a Substrate for in Vitro Endothelialization of PTFE Vascular Grafts,” Surgery 105(4):515-522 (1989). |
B.M. Alving et al. “Fibrin sealant: summary of a conference on characteristics and clinical uses,” The Journal of The American Association of Blood Banks 35:(9) 783-790 (Sep., 1995). |